“After treatment with trimetazidine and berberine , FMD value (14.02±2.39) was significantly increased compared with the level before treatment (P<0.05).”
“After treatment with trimetazidine and berberine , level of NO 50.75±2.75 mol/l was significantly increased compared with the level before treatment (P<0.05).”
“The results suggested that the combination of trimetazidine and berberine can increase the content of NO in blood and promote endothelium-dependent dilation function of brachial arteries, which is helpful in the treatment of CCP.”